クローン病における経壁的治癒の定義 (トレンチ 1) (TRENCH 1)
クローン病における経壁的治癒の定義 - TRENCH1 研究
Multicenter prospective cross-sectional study of CD patients, its aim is the construction of an objective and reproducible system for evaluation of Transmural healing in Crohn's Disease (CD).
Primary objective : Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD
調査の概要
詳細な説明
Number of patients : 210 patients, in 14 sites (only one investigator per site), 15 patients per site, 5 patients per grade of transmural healing based on the appraisal of a local reader pair (a gastroenterologist and a radiologist).
Recruitment period : 2 years
Primary Endpoint : Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD
Secondary Endpoints :
- To analyze intra- and inter-observer variability of radiological findings.
- To analyze intra- and inter-observer variability of TH definitions in CD.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
-
Amiens、フランス、80054
- CHU Amiens-Picardie (site Sud)
-
Bordeaux、フランス、33600
- CHU de Bordeaux - Hôpital Haut-Lévêque
-
Boulogne-Billancourt、フランス、92100
- APHP - Hôpital Ambroise Paré
-
Clermont-Ferrand、フランス、63003
- CHU de Clermont-Ferrand - Hôpital d'Estaing
-
Lille、フランス、59037
- CHRU de Lille - Hôpital Claude Huriez
-
Limoges、フランス、87000
- CHU Limoges Dupuytren
-
Marseille、フランス、13015
- AP-HM - Hôpital Nord
-
Montpellier、フランス、34295
- CHU de Montpellier - Hôpital Saint Eloi
-
Nantes、フランス、44093
- CHU de Nantes
-
Nîmes、フランス、30029
- CHU de Nîmes - Hôpital Carémeau
-
Pierre-Bénite、フランス、69475
- Hospices Civils de Lyon
-
Rennes、フランス、35033
- CHU Rennes - Hôpital Pontchaillou
-
-
-
-
-
Liège、ベルギー、4000
- CHU de Liège
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Patients diagnosed with CD for more than 6 months with histological confirmation available in his medical record, with an indication for MRE based on routine clinical practice validated by the treating physician
説明
Inclusion Criteria:
- ≥ 18 years of age
- Patient diagnosed with CD for more than 6 months with histological confirmation available in his medical record.
- Indication for MRE based on routine clinical practice validated by the treating physician
- Any CD treatment will be authorized, such as biologicals (infliximab, adalimumab, vedolizumab, ustekinumab…), or immunomodulators (azathioprine, 6-mercaptopurine, methotrexate…).
- The subjects sign and date a written, informed consent form and any required privacy authorization prior to the initiation of the study.
- A subject can be enrolled into the study only if the grade of TH (assessed by the LRP) corresponding to the subject is not already fulfilled.
Exclusion Criteria:
- Pregnancy during the study
- People unable to give consent (because of their physical or mental state)
- Absence of written consent
- Ulcerative colitis or unclassified IBD
- Specific postsurgical settings: ileoanal anastomosis, ileostomy or colostomy.
- Less than 3 evaluable ileocolic segments or more than 3 resected ileocolonic segments (not counting ileocecal valve)
- Severe obstructive symptoms
- Symptomatic intra-abdominal abscess
- Contraindication for MRI
- Isolated perianal disease without luminal location
- MRE images of poor quality, based on previously defined criteria
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD
時間枠:Day 1
|
An index (depth of remission) or score (grade of remission) will be constructed through multiple linear or logistic mixed regression models. |
Day 1
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Intra- and inter-observer variability of lesions observed per segment during MRE in CD
時間枠:Day 1
|
Variations in MRE readings images between the CR will be quantified through the Kappa coefficient for qualitative items and through the intraclass correlation coefficient for quantitative items. |
Day 1
|
|
Intra- and inter-observer variability of depth and grade of global transmural healing in CD
時間枠:Day 1
|
Variations in MRE readings images between the CR will be quantified through the Kappa coefficient for qualitative items and through the intraclass correlation coefficient for quantitative items. |
Day 1
|
協力者と研究者
捜査官
- 主任研究者:Sophie GEYL、CHU Limoge Dupuytren
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。